Literature DB >> 17275813

In vitro cultivation of Plasmodium falciparum: studies with modified medium supplemented with ALBUMAX II and various animal sera.

Kumkum Srivastava1, Shubhra Singh, Pratibha Singh, S K Puri.   

Abstract

RPNI, a combination of three commercially available growth media (RPMI-1640, NCTC-135 and IMDM) has been found to support long term continuous cultivation of 3D7 strain of Plasmodium falciparum in the presence of 10% bovine calf serum. During the present study, the suitability of this medium was evaluated for the development of P. falciparum in the presence of horse, goat and rabbit sera as well as various concentrations of ALBUMAX II. RPNI medium supplemented with 10% bovine calf serum (RPNI-BCS) was used as control. The cultures were maintained in candle jars protocol and parasitaemia was monitored daily up to day 7. Horse, goat and rabbit sera all supported the development of P. falciparum. Horse serum gave best results in RPNI medium and supported continuous culture up to day 100. The parasitaemia in the presence of ALBUMAX was significantly higher in RPNI than in RPMI-1640. Addition of hypoxanthine in RPMI-1640 caused an increase in parasitaemia whereas no obvious advantage could be observed in RPNI. The findings exhibited that medium RPNI has an edge over conventional RPMI-1640 medium for in vitro cultivation of P. falciparum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17275813     DOI: 10.1016/j.exppara.2006.12.003

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  8 in total

1.  In vitro adaptability of Plasmodium falciparum to different fresh serum alternatives.

Authors:  Chandrajit Dohutia; Pradyumna K Mohapatra; Dibya Ranjan Bhattacharyya; Kabita Gogoi; Khukumoni Bora; Basanta K Goswami
Journal:  J Parasit Dis       Date:  2016-06-30

Review 2.  Insights gained from P. falciparum cultivation in modified media.

Authors:  Sanjay A Desai
Journal:  ScientificWorldJournal       Date:  2013-07-09

3.  Lysophosphatidylcholine Regulates Sexual Stage Differentiation in the Human Malaria Parasite Plasmodium falciparum.

Authors:  Nicolas M B Brancucci; Joseph P Gerdt; ChengQi Wang; Mariana De Niz; Nisha Philip; Swamy R Adapa; Min Zhang; Eva Hitz; Igor Niederwieser; Sylwia D Boltryk; Marie-Claude Laffitte; Martha A Clark; Christof Grüring; Deepali Ravel; Alexandra Blancke Soares; Allison Demas; Selina Bopp; Belén Rubio-Ruiz; Ana Conejo-Garcia; Dyann F Wirth; Edyta Gendaszewska-Darmach; Manoj T Duraisingh; John H Adams; Till S Voss; Andrew P Waters; Rays H Y Jiang; Jon Clardy; Matthias Marti
Journal:  Cell       Date:  2017-11-09       Impact factor: 41.582

4.  Plasmodium falciparum in vitro continuous culture conditions: A comparison of parasite susceptibility and tolerance to anti-malarial drugs throughout the asexual intra-erythrocytic life cycle.

Authors:  Sandra Duffy; Vicky M Avery
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-07-15       Impact factor: 4.077

5.  In vitro susceptibility of Indian Plasmodium falciparum isolates to different antimalarial drugs & antibiotics.

Authors:  Pooja Agarwal; A R Anvikar; C R Pillai; Kumkum Srivastava
Journal:  Indian J Med Res       Date:  2017-11       Impact factor: 2.375

6.  Diagnostic Characteristics of Lactate Dehydrogenase on a Multiplex Assay for Malaria Detection Including the Zoonotic Parasite Plasmodium knowlesi.

Authors:  Rebecca Barney; Miguel Velasco; Caitlin A Cooper; Andrew Rashid; Dennis E Kyle; Robert W Moon; Gonzalo J Domingo; Ihn Kyung Jang
Journal:  Am J Trop Med Hyg       Date:  2021-11-15       Impact factor: 3.707

7.  Phagocytic uptake of oxidized heme polymer is highly cytotoxic to macrophages.

Authors:  Rohitas Deshmukh; Vishal Trivedi
Journal:  PLoS One       Date:  2014-07-31       Impact factor: 3.240

8.  Antiplasmodial Activity of Isolated Polyphenols from Alectryon serratus Leaves Against 3D7 Plasmodium falciparum.

Authors:  Uswatun Khasanah; Aty WidyaWaruyanti; Achmad Fuad Hafid; Mulyadi Tanjung
Journal:  Pharmacognosy Res       Date:  2017-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.